Neuphoria Therapeutics Inc. Common Stock (NEUP) is a publicly traded Healthcare sector company. As of July 2, 2026, NEUP trades at $3.56 with a market cap of $23.62M and a P/E ratio of -17.89. NEUP moved -19.91% today. Year to date, NEUP is -7.07%; over the trailing twelve months it is -49.43%. Its 52-week range spans $2.90 to $21.40. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces NEUP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Neuphoria Therapeutics Inc. Common Stock (NEUP) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NEUP moved -19.91% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $3.56 |
| Market Cap | $23.62M |
| P/E Ratio | -17.89 |
| EPS | $-0.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.40 |
| 52-Week Low | $2.90 |
| Volume | 634.48K |
| Avg Volume | 0 |
| Revenue (TTM) | $15.65M |
| Net Income | $-369.63K |
| Gross Margin | 0.00% |
1 analysts cover NEUP: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.